Profile | GDS4284 / 238783_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1474.64 | 80 |
GSM687648 | Patient 402 control | 1667 | 81 |
GSM687653 | Patient 403 control | 2157 | 85 |
GSM687658 | Patient 404 control | 1628.42 | 81 |
GSM687663 | Patient 411 control | 2073.42 | 84 |
GSM687668 | Patient 422 control | 1521.45 | 80 |
GSM687673 | Patient 424 control | 1780.81 | 82 |
GSM687678 | Patient 425 control | 2638.57 | 87 |
GSM687683 | Patient 427 control | 1874.74 | 83 |
GSM687688 | Patient 428 control | 2433.28 | 86 |
GSM687695 | Patient 441 control | 1529.67 | 82 |
GSM687699 | Patient 443 control | 980.279 | 74 |
GSM687704 | Patient 444 control | 2441.69 | 86 |
GSM687707 | Patient 448 control | 2313.74 | 86 |
GSM687712 | Patient 449 control | 1523.12 | 80 |
GSM687719 | Patient 450 control | 1658.57 | 81 |
GSM687724 | Patient 451 control | 3036.25 | 89 |
GSM687728 | Patient 452 control | 2323.98 | 86 |
GSM687646 | Patient 401 treated 24h | 1677.22 | 81 |
GSM687649 | Patient 402 treated 24h | 1987.63 | 83 |
GSM687665 | Patient 411 treated 24h | 2125.41 | 85 |
GSM687651 | Patient 402 treated 4 weeks | 1639.87 | 81 |
GSM687667 | Patient 411 treated 4 weeks | 1877.39 | 83 |
GSM687670 | Patient 422 treated 24h | 1585.7 | 80 |
GSM687671 | Patient 422 treated 4 weeks | 1812.35 | 82 |
GSM687654 | Patient 403 treated 24h | 2794.61 | 88 |
GSM687675 | Patient 424 treated 24h | 1407.92 | 79 |
GSM687685 | Patient 427 treated 24h | 2976.95 | 89 |
GSM687656 | Patient 403 treated 4 weeks | 1740.25 | 82 |
GSM687677 | Patient 424 treated 4 weeks | 2208.6 | 85 |
GSM687687 | Patient 427 treated 4 weeks | 1884.75 | 83 |
GSM687692 | Patient 428 treated 4h | 1802.09 | 82 |
GSM687716 | Patient 449 treated 4h | 1830.24 | 83 |
GSM687722 | Patient 450 treated 4h | 1213.23 | 77 |
GSM687680 | Patient 425 treated 24h | 2169.13 | 85 |
GSM687690 | Patient 428 treated 24h | 1551.55 | 81 |
GSM687700 | Patient 443 treated 24h | 1405.81 | 79 |
GSM687705 | Patient 444 treated 24h | 2283.33 | 86 |
GSM687714 | Patient 449 treated 24h | 1032.97 | 75 |
GSM687721 | Patient 450 treated 24h | 1118.36 | 76 |
GSM687682 | Patient 425 treated 4 weeks | 4101.98 | 92 |
GSM687694 | Patient 428 treated 4 weeks | 1479.65 | 79 |
GSM687702 | Patient 443 treated 4 weeks | 1166.49 | 76 |
GSM687718 | Patient 449 treated 4 weeks | 1328.56 | 78 |
GSM687723 | Patient 450 treated 4 weeks | 1424.68 | 79 |
GSM687661 | Patient 404 treated 4h | 1037.07 | 74 |
GSM687710 | Patient 448 treated 4h | 2306.69 | 86 |
GSM687726 | Patient 451 treated 4h | 2653.96 | 87 |
GSM687730 | Patient 452 treated 4h | 3052.52 | 90 |
GSM687660 | Patient 404 treated 24h | 943.244 | 75 |
GSM687697 | Patient 441 treated 24h | 1961.78 | 84 |
GSM687709 | Patient 448 treated 24h | 2048.67 | 84 |
GSM687725 | Patient 451 treated 24h | 3391.95 | 90 |
GSM687729 | Patient 452 treated 24h | 1189.73 | 79 |
GSM687727 | Patient 451 treated 4 weeks | 4880.54 | 93 |
GSM687731 | Patient 452 treated 4 weeks | 2198.92 | 85 |